Actively Recruiting / Ongoing Studies

ParticipateResearch

Participate in Research

Interested in research? Check out the current Bronchiectasis and NTM studies listed below.

Still fighting MAC lung disease despite treatment? You may qualify for the ICON-1 Study

If you or a loved one is living with mycobacterium avium complex (MAC) lung disease and has been on antibiotic treatment for at least six (6) months, you may be eligible for a new clinical study.

The ICON-1 Study is researching an investigational inhaled antibiotic to see if it can provide a more targeted approach for MAC lung infections. Participants will receive study-related care at no cost and will be closely monitored by specialists.

To qualify, you must:

  • Be 18 or older
  • Have a diagnosed MAC lung infection
  • Have been on certain antibiotics for 6+ months

We’ve teamed up with Leapcure to help support this research. If you are interested in learning more, fill out a few short questions to see if you’re eligible.

Together, we can help advance potential new treatment options for MAC lung disease.

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease (MAC2v3)

There are many different types of NTM, but mycobacterium avium complex (also known as ‘MAC’) is the most common. Treatment for MAC lung infections typically consists of a multi-drug (typically 3) antibiotic therapy for 18 to 24 months. When patients are on this treatment, they frequently experience debilitating side effects which can include nausea, diarrhea, fatigue, and in rare cases, more serious side effects such as hearing loss. Oregon Health and Science University is currently conducting a clinical trial to determine whether a third drug is necessary or whether taking two drugs can increase tolerability without a substantial loss of efficacy. To learn more about this study, click here.

Note to Researchers: The Bronchiectasis and NTM Research Registry is available to researchers conducting research studies and/or clinical trials. Researchers will go through an application process, which involves Advisory Committee approval for the use of the Registry. The Registry can be used for recruitment and/or data analysis. For more information on use of the Registry for research, please see the ‘For Healthcare Providers’ section on the Bronchiectasis and NTM Research Registry page.